Displaying items by tag: school of medicine

A biomarker, endothelial mitochondrial function, may be useful for early identification of newborn babies at risk for lung disease and could enable novel therapy approaches.
Brian Samuels, M.D., says there is an increase of eye pressure throughout the morning, and that pressure comes and goes throughout the day. This fluctuation is a known risk factor for the progression of glaucoma.
The UAB Cancer Center offers patients with advanced and rare cancer, including those with any stage of pancreatic and brain cancer, the opportunity to have no-cost tumor profiling, and patients may be matched with an appropriate clinical trial or recommend use of an FDA-approved drug.
One of the most common types of cancer is skin cancer. A UAB dermatologist shares background information, risks and how to protect your skin.
Funding to UAB for medical research by the National Institutes of Health topped $238 million in 2016, driving innovation and growth.
Successful Phase III trials at UAB contributed to the development of a novel “corrector-potentiator” combination drug therapy for cystic fibrosis patients.
These scientifically diverse researchers deliver lectures at American Society for Microbiology Branch meetings throughout the United States.
Seven rising second-year medical students have been chosen for the first class of the School of Medicine’s new Health Equity Scholars Program, created earlier this year to prepare students with skills to work with medically underserved populations.
Sadis Matalon, Ph.D., Dr.Sc. (Hon), distinguished professor in the Department of Anesthesiology and Perioperative Medicine, has been tapped to become editor-in-chief of the American Physiological Society’s Physiological Reviews effective January 2018.
Page 42 of 140